NANO-CAN — NANOFTONIC CANCER FOR FIGHTING CANCER (Q2023743): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Label in wikidata changed) |
(Created claim: summary (P836): THE MAIN OBJECTIVE CONCERNS THE DEVELOPMENT OF INNOVATIVE PLATFORMS FOR IN VIVO THERANOSTICS BASED ON OPTICAL FIBRE ADVANCED TECHNOLOGY, THROUGH A SINGLE DEVICE, WHICH IS ACHIEVED THROUGH THE INTEGRATION OF SEVERAL DIFFERENT FIBRES OF FIBRE, ENGINEERED FOR THE SPECIFIC APPLICATION AND INTEGRATED IN MEDICAL NEEDLES. IT WILL BE POSSIBLE TO HAVE A SINGLE INSTRUMENT CAPABLE OF SIMULTANEOUSLY DIAGNOSING AND TREATING THE PATIENT, IN VIVO, WITHIN THE B...) |
||
| Property / summary | |||
THE MAIN OBJECTIVE CONCERNS THE DEVELOPMENT OF INNOVATIVE PLATFORMS FOR IN VIVO THERANOSTICS BASED ON OPTICAL FIBRE ADVANCED TECHNOLOGY, THROUGH A SINGLE DEVICE, WHICH IS ACHIEVED THROUGH THE INTEGRATION OF SEVERAL DIFFERENT FIBRES OF FIBRE, ENGINEERED FOR THE SPECIFIC APPLICATION AND INTEGRATED IN MEDICAL NEEDLES. IT WILL BE POSSIBLE TO HAVE A SINGLE INSTRUMENT CAPABLE OF SIMULTANEOUSLY DIAGNOSING AND TREATING THE PATIENT, IN VIVO, WITHIN THE BODY OF THE PATIENT. (English) | |||
| Property / summary: THE MAIN OBJECTIVE CONCERNS THE DEVELOPMENT OF INNOVATIVE PLATFORMS FOR IN VIVO THERANOSTICS BASED ON OPTICAL FIBRE ADVANCED TECHNOLOGY, THROUGH A SINGLE DEVICE, WHICH IS ACHIEVED THROUGH THE INTEGRATION OF SEVERAL DIFFERENT FIBRES OF FIBRE, ENGINEERED FOR THE SPECIFIC APPLICATION AND INTEGRATED IN MEDICAL NEEDLES. IT WILL BE POSSIBLE TO HAVE A SINGLE INSTRUMENT CAPABLE OF SIMULTANEOUSLY DIAGNOSING AND TREATING THE PATIENT, IN VIVO, WITHIN THE BODY OF THE PATIENT. (English) / rank | |||
Normal rank | |||
Revision as of 09:22, 23 March 2020
Project in Italy financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NANO-CAN — NANOFTONIC CANCER FOR FIGHTING CANCER |
Project in Italy financed by DG Regio |
Statements
2,821,849.8 Euro
0 references
3,762,466.4 Euro
0 references
75.0 percent
0 references
1 January 2018
0 references
31 December 2020
0 references
CERICT SCRL - CENTRO REGIONALE INFORMATION COMMUNICATION TECHNOLOGY
0 references
TEORESI S.P.A
0 references
BIOPOX S.R.L
0 references
REGIONE CAMPANIA
0 references
TECNO-BIOS SRL
0 references
L'OBIETTIVO PRINCIPALE RIGUARDA LO SVILUPPO DI PIATTAFORME INNOVATIVE PER LA TERANOSTICA IN VIVO BASATE SU TECNOLOGIA AVANZATA IN FIBRA OTTICA, ATTRAVERSO UN SOLO DISPOSITIVO, OTTENUTO MEDIANTE INTEGRAZIONE DI DIVERSI PROBE MULTIFUNZIONALI IN FIBRA, INGEGNERIZZATI PER LA SPECIFICA APPLICAZIONE E INTEGRATI IN AGHI MEDICALI. SARÃ POSSIBILE AVERE UN UNICO STRUMENTO CAPACE DI EFFETTUARE CONTEMPORANEAMENTE DIAGNOSI E TERAPIA, OSSIA TERANOSTICA, IN VIVO, ALL'INTERNO DEL CORPO DEL PAZIENTE. (Italian)
0 references
THE MAIN OBJECTIVE CONCERNS THE DEVELOPMENT OF INNOVATIVE PLATFORMS FOR IN VIVO THERANOSTICS BASED ON OPTICAL FIBRE ADVANCED TECHNOLOGY, THROUGH A SINGLE DEVICE, WHICH IS ACHIEVED THROUGH THE INTEGRATION OF SEVERAL DIFFERENT FIBRES OF FIBRE, ENGINEERED FOR THE SPECIFIC APPLICATION AND INTEGRATED IN MEDICAL NEEDLES. IT WILL BE POSSIBLE TO HAVE A SINGLE INSTRUMENT CAPABLE OF SIMULTANEOUSLY DIAGNOSING AND TREATING THE PATIENT, IN VIVO, WITHIN THE BODY OF THE PATIENT. (English)
0 references
Identifiers
B51C17000050007
0 references